Gurgaon RERA Approves Rs 86,588 Crore Projects in 2025
Gurgaon's property market surged in 2025 as RERA approved 131 projects worth Rs 86,588 crore, including 35,455 units, with residential and commercial developments driving growth.
Gurgaon's property market surged in 2025 as RERA approved 131 projects worth Rs 86,588 crore, including 35,455 units, with residential and commercial developments driving growth.
Uttar Pradesh Chief Minister Yogi Adityanath praised the PRAGATI portal for accelerating project approvals and boosting infrastructure development across the state.
Five years after Jal Jeevan Mission launch, 51 Uttarkashi villages remain without tap water. Residents face daily struggles fetching water, with forest approvals delaying Rs 121 crore projects.
UP RERA approves seven new residential and commercial projects across five cities, involving an investment of Rs 417 crore and adding 1,024 units. This move aims to boost real estate development and generate employment.
India's Dalal Street braces for a historic IPO surge in 2026, with 197 firms eyeing $31 billion. Jio Platforms, NSE, and Flipkart to lead the wave. Discover the new market trends.
Senior Congress leader Jairam Ramesh demands Supreme Court action against retrospective environmental clearances, calling them a mockery of governance. Details on the Sariska boundary revision case.
Mora Namdar, daughter of Iranian immigrants, takes charge of US visa approvals and passport issuance. A lawyer and business owner, her role is crucial for migrants and US citizens abroad. Read more.
Indian govt notifies Colliery Control (Amendment) Rules, 2025, shifting mine opening approvals to company boards. This reform aims to slash bureaucratic delays by up to 60 days, boosting coal production efficiency.
Lupin receives a Voluntary Action Indicated (VAI) classification from the USFDA for its Nagpur injectables facility after a September 2025 inspection. Read the full details.
K-RERA chairman Rakesh Singh announces plans for a single-window system to streamline approvals for real estate projects, promising deemed approvals if agencies delay. Read more.
Granules India's US subsidiary, Granules Consumer Health LLC, successfully cleared a USFDA GMP inspection with zero observations. This marks a significant achievement for the Hyderabad-based pharma major's OTC product operations in America.
USFDA warns against using cookware from 4 Indian companies due to dangerous lead leaching. Check your kitchen for these recalled products to protect your family's health.
Wockhardt's share price surged over 6% after the USFDA accepted its New Drug Application for Zaynich, a novel antibiotic. Discover the details and market impact.
Mumbai's Wockhardt creates history as USFDA accepts its New Drug Application for antibiotic Zaynich, a first for an Indian firm. Shares surge 19%. Read more.
Ahmedabad Municipal Corporation approves 17 tall buildings over 70 meters, generating ₹250 crore revenue. Western areas see massive development with 38 buildings exceeding 100 meters height across city.
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Lupin stocks trade at 21.7x P/E despite record earnings and 80 new products pipeline. Discover why this pharma giant might be undervalued and poised for next growth cycle with biosimilars and complex generics.
Madhya Pradesh Cabinet chaired by CM Dr Mohan Yadav approves multiple decisions including housing schemes, welfare measures, and administrative approvals. Key focus on public welfare and development.
Supreme Court Justice Ujjal Bhuyan delivers sharp dissent against retrospective environmental clearances, calling them 'anathema' to environmental law. Read the full analysis.
Supreme Court recalls verdict barring post-facto environmental clearances through 2:1 majority decision. Chief Justice Gavai leads bench reviewing Vanshakti judgment. Read full analysis.
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Karnataka Chief Minister Siddaramaiah issues stern warning to officials causing investment delays, demands faster clearances to match other states' efficiency.
RBL Bank's strategic shift from private to listed foreign bank status gains momentum as Emirates NBD anticipates regulatory approvals within 5-6 months, marking a significant evolution in India's banking landscape.